2021 Q3 Form 10-Q Financial Statement

#000164033421002009 Filed on August 23, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.10K $19.18K $10.00K
YoY Change 51.0% 91.8%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $15.10K $19.18K $6.747K
YoY Change 160.7% 184.26%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$15.10K -$19.18K -$10.00K
YoY Change 51.0% 91.8%
Income Tax
% Of Pretax Income
Net Earnings -$15.10K -$19.18K -$6.747K
YoY Change 160.7% 184.26%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.960K -$2.489K $0.00
COMMON SHARES
Basic Shares Outstanding 7.705M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.570K $1.220K $0.00
YoY Change
Cash & Equivalents $1.570K $1.220K $1.266K
Short-Term Investments
Other Short-Term Assets $2.500K $2.500K $0.00
YoY Change
Inventory
Prepaid Expenses $2.500K $2.500K
Receivables
Other Receivables
Total Short-Term Assets $4.070K $3.720K $10.00K
YoY Change -62.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.070K $3.720K $10.00K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $4.070K $3.720K $10.00K
YoY Change -62.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.75K $15.30K $20.00K
YoY Change 3.75% -23.5% 0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $134.6K $119.2K $80.00K
YoY Change 68.29% 48.98% 60.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $134.6K $119.2K $80.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $134.6K $119.2K $80.00K
YoY Change 68.29% 48.98% 60.0%
SHAREHOLDERS EQUITY
Retained Earnings -$180.6K -$165.5K
YoY Change
Common Stock $77.00 $77.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$130.6K -$115.5K -$74.31K
YoY Change
Total Liabilities & Shareholders Equity $4.070K $3.720K $10.00K
YoY Change -62.8%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$15.10K -$19.18K -$6.747K
YoY Change 160.7% 184.26%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$150.00 -$209.00 -$148.00
YoY Change 41.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0
YoY Change
NET CHANGE
Cash From Operating Activities -150.0 -$209.00 -$148.00
Cash From Investing Activities
Cash From Financing Activities 500.0
Net Change In Cash 350.0 -$209.00 -$148.00
YoY Change 41.22%
FREE CASH FLOW
Cash From Operating Activities -$150.00 -$209.00 -$148.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7705000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-96282 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19179 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-115461 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-67562 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6747 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-74309 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19179 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6747 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3853 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18970 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10452 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-209 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148 USD
CY2021Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-209 USD
CY2020Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-148 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1429 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1414 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1220 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1266 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q2 caro Operating Expenses Paid By Related Party
OperatingExpensesPaidByRelatedParty
16500 USD
CY2020Q2 caro Operating Expenses Paid By Related Party
OperatingExpensesPaidByRelatedParty
5832 USD
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7705000 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1220 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1429 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2500 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2500 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
3720 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
3929 USD
CY2021Q2 us-gaap Assets
Assets
3720 USD
CY2021Q1 us-gaap Assets
Assets
3929 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15303 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12833 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
103878 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
87378 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
119181 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
100211 USD
CY2021Q2 us-gaap Liabilities
Liabilities
119181 USD
CY2021Q1 us-gaap Liabilities
Liabilities
100211 USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
77 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
77 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49973 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49973 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165511 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146332 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-115461 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-96282 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3720 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3929 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19179 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6747 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
19179 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
6747 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19179 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-6747 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7705000 shares
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165511 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-19179 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
103878 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
87378 USD

Files In Submission

Name View Source Status
0001640334-21-002009-index-headers.html Edgar Link pending
0001640334-21-002009-index.html Edgar Link pending
0001640334-21-002009.txt Edgar Link pending
0001640334-21-002009-xbrl.zip Edgar Link pending
caro-20210630.xsd Edgar Link pending
caro-20210630_cal.xml Edgar Link unprocessable
caro-20210630_def.xml Edgar Link unprocessable
caro-20210630_lab.xml Edgar Link unprocessable
caro-20210630_pre.xml Edgar Link unprocessable
caro_10q.htm Edgar Link pending
caro_10q_htm.xml Edgar Link completed
caro_ex311.htm Edgar Link pending
caro_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending